SEC
SlamSEC
Search
Browse
Earnings
C4 Therapeutics, Inc. — SlamSEC
C4 Therapeutics, Inc.
Nasdaq:
CCCC
Biological Products, (No Diagnostic Substances)
·
WATERTOWN, MA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Credit & Agreements
material agreements · debt obligations
Credit & Agreements
(8-K)
5 shown
Filed
Description
10/16/25
1.01
Material Agreement
→
3/4/24
1.01
Material Agreement
→
12/12/23
1.01
Material Agreement
→
5/30/23
1.01
Material Agreement
→
11/30/21
1.01
2.03
Material Agreement · New Debt Obligation
→
CEO
Hirsch Andrew
CFO
Adams Kendra